Keymed Biosciences Co.Ltd: all 69 studies
Page 1 of 1. Open to participants first (34), then studies with results posted, then the rest; newest registration first within each.
- Study of CM529D1 in Participants With Advanced Solid TumorsNot yet recruitingNCT07893171Phase 1/2
- Study of CM512 Injection in Patients With Perennial Allergic Rhinitis on Background TherapyNot yet recruitingNCT07890350Phase 2
- Study of CM583 in Healthy ParticipantsNot yet recruitingNCT07823764Phase 1
- A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis (NEZHA-3)Not yet recruitingNCT07807826Phase 3
- CM336 for Active Sjogren's Syndrome StudyNot yet recruitingNCT07642843Phase 1
- A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-2）Not yet recruitingNCT07519577Phase 2
- Study of CM383 in Healthy SubjectsRecruitingNCT07292688Phase 1
- A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.RecruitingNCT07230483Phase 2
- Study of CM336 in Relapsed or Refractory Multiple Myeloma PatientsNot yet recruitingNCT07181239Phase 3
- Study of CM559 in Healthy SubjectsRecruitingNCT07175506Phase 1
- A Study of CM336 in Patients With Relapsed or Refractory Autoimmune CytopeniaRecruitingNCT07175493Phase 1/2
- Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU)RecruitingNCT07166211Phase 2
- A Study of Stapokibatrt in Children Subjects With Atopic DermatitisNot yet recruitingNCT07106372Phase 3
- Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain AmyloidosisRecruitingNCT07039578Phase 2
- Study of CM518D1 in Patients With Advanced Solid TumorsRecruitingNCT07019779Phase 1/2
- Study of CM512 Injection in Subjects With Moderate-to-severe AsthmaRecruitingNCT07011524Phase 2
- A Study of CM512 in Subjects With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseNot yet recruitingNCT06980142Phase 2
- Study of Stapokibatrt in Children Subjects With Atopic DermatitisNot yet recruitingNCT06956196Phase 3
- Study of CM512 in Patients With Moderate-to-Severe Atopic DermatitisRecruitingNCT06947980Phase 2
- Study of CM313 in Subject With IgA NephropathyNot yet recruitingNCT06830395Phase 2
- Study of CM313(SC) Injection in Subjects With Platelet Transfusion RefractorinessRecruitingNCT06792019Phase 1/2
- Study of CM313(SC) Injection in Subjects With Relapsed/Refractory Aplastic AnemiaNot yet recruitingNCT06791824Phase 1/2
- Study of CM313(SC) Injection in Systemic Lupus Erythematosus(SLE)Not yet recruitingNCT06791772Phase 2
- A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's DiseaseRecruitingNCT06619613Phase 1
- Study of Stapokibart Injection in Patients With Allergic RhinitisRecruitingNCT06525597Phase 2
- Single Dose Escalation Study of CM383 in Healthy VolunteersRecruitingNCT06412185Phase 1
- Study of CM326 in Participants With Chronic Rhinosinusitis With Nasal PolyposisNot yet recruitingNCT06372678Phase 2
- Study of CM313 in Healthy SubjectsRecruitingNCT06285227Phase 1
- Study of CM310 in Subjects With Seasonal Allergic RhinitisNot yet recruitingNCT06171074Phase 2
- Study Evaluating the Pharmacokinetics of CM310 in Healthy SubjectsNot yet recruitingNCT06171048Phase 1
- A Study of CM313 in Subjects With Relapsed or Refractory Multiple MyelomaNot yet recruitingNCT06126237Phase 1/2
- Clinical Study of CM338 in the Treatment of Immunoglobulin A NephropathyRecruitingNCT05775042Phase 2
- A Study of CM336 in Patients With Relapsed or Refractory Multiple MyelomaRecruitingNCT05299424Phase 1/2
- A Study of CM350 in Patients With Advanced Solid TumorsRecruitingNCT05263960Phase 1/2
- A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-1）CompletedNCT06930612Phase 2
- Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP)Active, not recruitingNCT06594146Phase 2
- Study of CM512 in Healthy Subjects and Patients With Atopic DermatitisCompletedNCT06553209Phase 1
- Study of CM310 in Adolescent Subjects With Atopic DermatisActive, not recruitingNCT06495229Phase 3
- Study on the Treatment of Prurigo Nodularis With Stapokibart InjectionCompletedNCT06424470Phase 3
- Study of CM310 Injection in Adolescent Subjects With Atopic DermatisCompletedNCT06277765Phase 3
- Study of CM310 in Children Subjects With Moderate-to-severe Atopic DermatisCompletedNCT06162507Phase 1/2
- Study of CM310 in Healthy SubjectsCompletedNCT06161090Phase 1
- A Study of CM310 in Subjects With Moderate-to-Severe Atopic DermatitisCompletedNCT06116565Phase 2
- Study of CM310 in Patients With Allergic RhinitisCompletedNCT05908721Phase 2
- Study of CM310 in Subjects With Allergic RhinitisCompletedNCT05908032Phase 3
- Study of CM326 Injection in Healthy SubjectsCompletedNCT05715333Phase 1
- Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic DermatitisCompletedNCT05715320Phase 2
- Study to Evaluate Pharmacokinetics, Safety and Efficacy of CM310CompletedNCT05702450Phase 1
- The Study of CM326 in Adult Subjects With Atopic DermatitisStatus unknownNCT05671445Phase 2
- The Study of CM326 in Moderate-to-severe Atopic DermatitisStatus unknownNCT05671432Phase 2
- A Study of CM310 in Children Patients With Moderate-to-severe Atopic DermatisCompletedNCT05579925Phase 2
- A Study of CM313 Injection in Subjects With Systemic Lupus ErythematosusStatus unknownNCT05465707Phase 1/2
- A Study of CM310 in Subjects With Chronic PruritusStatus unknownNCT05452343Phase 2
- A Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （CROWNS-2）CompletedNCT05436275Phase 3
- Multiple Ascending Dose Study of CM338 in Healthy VolunteersCompletedNCT05371379Phase 1
- A Study of CM326 in Patients With Chronic Rhinosinusitis With Nasal PolypsCompletedNCT05324137Phase 1/2
- A Study of CM310 in Patients With Moderate-to-Severe Atopic DermatitisCompletedNCT05265923Phase 3
- The Study of CM326 in Patients With Moderate-to-severe Atopic DermatitisStatus unknownNCT05186922Phase 1/2
- A Study of CM310 in Subjects With Moderate to Severe AsthmaCompletedNCT05186909Phase 2
- Single Ascending Dose Study of CM338 in Healthy VolunteersCompletedNCT05186285Phase 1
- A Multiple Ascending Doses Study of CM326 Injection in Healthy SubjectsCompletedNCT05171348Phase 1
- The Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal PolypsCompletedNCT05131464Phase 2
- Dose Escalation Trial of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis (AD)CompletedNCT04893941Phase 1/2
- The Study of CM310 in Patients With Atopic DermatitisCompletedNCT04893707Phase 2
- Single Ascending Dose Study of CM326 in Healthy VolunteersCompletedNCT04842201Phase 1
- Dose Escalation and Expansion Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma and LymphomaStatus unknownNCT04818372Phase 1
- Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD)CompletedNCT04805411Phase 2
- Subcutaneously CM310/Placebo in Patients With Chronic Rhinosinusitis With Nasal Polyposis (CROWNS-1)CompletedNCT04805398Phase 2
- Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901CompletedNCT04805307Phase 1